Lazard earns $44m-plus on five Pfizer deals in 18 months

Pfizer, the world's largest pharmaceutical group, has sold its Swedish-based diagnostic allergy-testing business to PPM Ventures and Triton, two European private equity houses, for $575m (€459m).

The deal brings to more than $44m the total fees earned by Lazard on five Pfizer deals in the past 18 months, according to estimates from Dealogic, the data provider.

WSJ Logo
Pro Bono or Pro Nono? Law Firms Split on Fulfilling Deals With TrumpExternal link

Pro Bono or Pro Nono? Law Firms Split on Fulfilling Deals With Trump